Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Older men with diabetes were more likely to get severe COVID-19 and needed treatments like antivirals for about 2-3 weeks.

Low testosterone and SHBG levels are linked to higher COVID-19 death rates.

Men generally face more severe COVID-19 outcomes than women, partly due to hormonal differences.

The ACE1 gene variant doesn't affect long-COVID symptoms.

Hydroxychloroquine and chloroquine are not recommended for COVID-19 treatment due to insufficient evidence and safety concerns.

Different ACE2 gene versions may affect COVID-19 impact based on age and suggest some hair loss drugs could be potential treatments.

Nitric oxide may help treat COVID-19 pneumonia by fighting the virus and easing symptoms.

Using mesenchymal stem cells or their exosomes is safe for COVID-19 patients and helps improve lung healing and oxygen levels.

Age, health conditions, race, and gender affect COVID-19 risk.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

Anti-androgens might help reduce COVID-19 severity in men.

Men are more at risk for severe COVID-19 due to biological differences, suggesting the need for targeted treatments.

Anti-androgen therapy might help protect against COVID-19 infection and reduce death risk.

Natural products might help treat COVID-19, but current drugs like hydroxychloroquine haven't worked.

Tailored neurorehabilitation programs improve life quality for post-COVID-19 patients.

Long-lasting symptoms like fatigue and breathlessness can persist after COVID-19, requiring ongoing medical follow-up.

Females have stronger immune responses to COVID-19 than males, leading to better outcomes.

MX1 and AR genes are linked to milder COVID-19, while TMPRSS2 increases severe risk, especially in women.

Men with androgenetic alopecia and hypertension may experience more severe COVID-19.

Dutasteride treatment in men with mild to moderate COVID-19 reduced viral shedding, inflammation, and recovery time without serious side effects.

Reprogramming macrophages to resolve inflammation can help reduce severe COVID-19 complications.

Common dermatology drugs were considered but are controversial for COVID-19 treatment.

Men with higher androgen levels may have severe COVID-19 symptoms, but those on antiandrogen therapy are less likely to contract the virus and have milder symptoms. Anti-androgen drugs could potentially treat COVID-19, but more research is needed.

Higher ACE2 levels in certain tissues may worsen COVID-19 in people with other health issues, especially older adults.

Diet and nutrients, including lycopene from tomatoes and hydroquinone from wheat, can help control melasma, a skin condition.

Nearly half of the studied men with long COVID had low testosterone, including younger men.

Your lifestyle and health can affect your chances of getting COVID-19; not enough sleep, lots of exercise, and hair loss can increase risk, while washing hands, eating fruit daily, and taking vitamins A and C can lower it.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

A standardized drug development platform is essential for efficient and effective drug repurposing, especially during pandemics.